Edition:
United Kingdom

Allogene Therapeutics Inc (ALLO.OQ)

ALLO.OQ on NASDAQ Stock Exchange Global Select Market

28.86USD
5:50pm BST
Change (% chg)

$0.92 (+3.29%)
Prev Close
$27.94
Open
$27.91
Day's High
$29.18
Day's Low
$27.88
Volume
49,235
Avg. Vol
149,861
52-wk High
$35.55
52-wk Low
$21.67

About

Allogene Therapeutics, Inc. is a clinical stage immuno-oncology company. The Company is focused on developing and commercializing of allogeneic T cell therapies for the treatment of cancer. It is involved in developing a pipeline of multiple allogeneic chimeric antigen receptor (CAR) T cell product candidates utilizing protein... (more)

Overall

Beta: --
Market Cap(Mil.): $3,394.23
Shares Outstanding(Mil.): 121.48
Dividend: --
Yield (%): --

Financials

  ALLO.OQ Industry Sector
P/E (TTM): -- 107.11 59.93
EPS (TTM): -1.82 -- --
ROI: -- 8.08 11.86
ROE: -- 8.26 12.88

Earnings vs. Estimates